Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
54.28
+0.34 (0.63%)
Jun 6, 2025, 4:00 PM - Market closed
Akero Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 185.92 | 340.24 | 234.21 | 249.77 | 150.48 | 187.24 | Upgrade
|
| Short-Term Investments | 500.37 | 402.84 | 315.8 | 101.68 | 37.78 | 81.15 | Upgrade
|
| Cash & Short-Term Investments | 686.29 | 743.08 | 550.01 | 351.45 | 188.26 | 268.39 | Upgrade
|
| Cash Growth | -24.05% | 35.10% | 56.50% | 86.69% | -29.86% | 96.77% | Upgrade
|
| Prepaid Expenses | 26.86 | 27.3 | 9.95 | 3.72 | 5.32 | 2.96 | Upgrade
|
| Total Current Assets | 713.15 | 770.38 | 559.96 | 355.17 | 193.58 | 271.35 | Upgrade
|
| Property, Plant & Equipment | 0.69 | 0.76 | 1.03 | 1.29 | 1.55 | 1.79 | Upgrade
|
| Long-Term Investments | 442 | 54.75 | 19.28 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.11 | 0.42 | 0.2 | Upgrade
|
| Total Assets | 1,156 | 825.89 | 580.27 | 356.57 | 195.55 | 273.34 | Upgrade
|
| Accounts Payable | 10.83 | 9.03 | 7.04 | 7.97 | 6.71 | 3.43 | Upgrade
|
| Accrued Expenses | 24.3 | 30.1 | 11.57 | 10.79 | 18.22 | 9.39 | Upgrade
|
| Current Portion of Leases | 0.3 | 0.29 | 0.52 | 0.33 | 0.21 | 0.29 | Upgrade
|
| Other Current Liabilities | 0.35 | 0.34 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 42.44 | 39.75 | 19.13 | 19.08 | 25.13 | 13.11 | Upgrade
|
| Long-Term Debt | 28.81 | 35.3 | 24.96 | 9.54 | - | - | Upgrade
|
| Long-Term Leases | 0.45 | 0.53 | 0.82 | 1.08 | 1.31 | 1.52 | Upgrade
|
| Other Long-Term Liabilities | 0.3 | 0.19 | 0.05 | 0.31 | - | - | Upgrade
|
| Total Liabilities | 72 | 75.77 | 44.97 | 30.01 | 26.44 | 14.63 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,980 | 1,575 | 1,109 | 748.86 | 479.44 | 468.24 | Upgrade
|
| Retained Earnings | -896.88 | -826.16 | -574.1 | -422.34 | -310.3 | -209.53 | Upgrade
|
| Comprehensive Income & Other | 1.09 | 0.95 | 0.27 | 0.04 | -0.03 | -0 | Upgrade
|
| Total Common Equity | 1,084 | 750.11 | 535.31 | 326.56 | 169.11 | 258.71 | Upgrade
|
| Shareholders' Equity | 1,084 | 750.11 | 535.31 | 326.56 | 169.11 | 258.71 | Upgrade
|
| Total Liabilities & Equity | 1,156 | 825.89 | 580.27 | 356.57 | 195.55 | 273.34 | Upgrade
|
| Total Debt | 36.23 | 36.12 | 26.31 | 10.95 | 1.52 | 1.81 | Upgrade
|
| Net Cash (Debt) | 1,092 | 761.71 | 542.99 | 340.5 | 186.74 | 266.58 | Upgrade
|
| Net Cash Growth | 25.84% | 40.28% | 59.47% | 82.34% | -29.95% | 95.56% | Upgrade
|
| Net Cash Per Share | 15.17 | 11.35 | 10.33 | 8.73 | 5.36 | 8.47 | Upgrade
|
| Filing Date Shares Outstanding | 79.72 | 79.62 | 56.3 | 46.97 | 35.01 | 34.77 | Upgrade
|
| Total Common Shares Outstanding | 79.67 | 72.38 | 55.75 | 46.87 | 34.9 | 34.74 | Upgrade
|
| Working Capital | 670.71 | 730.63 | 540.83 | 336.09 | 168.45 | 258.23 | Upgrade
|
| Book Value Per Share | 13.60 | 10.36 | 9.60 | 6.97 | 4.85 | 7.45 | Upgrade
|
| Tangible Book Value | 1,084 | 750.11 | 535.31 | 326.56 | 169.11 | 258.71 | Upgrade
|
| Tangible Book Value Per Share | 13.60 | 10.36 | 9.60 | 6.97 | 4.85 | 7.45 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.